VirtualScopics Inc fka VSCP

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

nickygee12 Free

05/06/16 9:24 AM

Post #67

Hi Folks, there has been another offer made to the VSCP BoD at $5.05 a share for common shares that would keep VSCP public and a separate entity. I have reviewed the letter to the BoD but don't think I can attach it here. Here is a link to once announcement though:

http://nanotechnews.com/gastineau-partners-llc-and-affiliated-investors-announce-25-premium-offer-of-5-05-per-common-share-of-virtualscopics-inc-vscp/

MJames89

03/28/16 3:56 PM

Post #66

VirtualScopics Shareholders Should Refuse To Tender Their Shares To BioTelemetry

http://seekingalpha.com/article/3961227-virtualscopics-shareholders-refuse-tender-shares-biotelemetry

Join this group if you are against this ripoff deal:

https://www.facebook.com/groups/262495280756635/

crudeoil24 PremiumMember

03/26/16 9:36 AM

Post #65

Re: #64: @crudeoil24 - BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.

>> 8-K > 3/25/16 > Solid revenue growth > increased revenues, increased gross profits year over year. > should take a "pop" Monday morning. Merger isn't until April.

crudeoil24 PremiumMember

03/25/16 2:12 PM

Post #64

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.
2 hours 19 minutes ago - DJNF

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.
MALVERN, Pa. and ROCHESTER, N.Y., March 25, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, announced today that the two companies have entered into a definitive agreement whereby BioTelemetry will acquire VirtualScopics.

BioTelemetry will commence an all cash tender offer for all outstanding common and preferred shares of VirtualScopics. In the tender offer, BioTelemetry will offer investors $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock. The total purchase consideration is approximately $15.5 million.

The tender offer is expected to commence on or about April 11, 2016, and will be open for a minimum of 20 business days. VirtualScopics' Board has approved the transaction and has agreed to unanimously recommend to its stockholders that they tender their shares of VirtualScopics' common and preferred stock in the tender offer. Stockholders holding approximately 20% of VirtualScopics' current outstanding voting stock have agreed, among other things, to tender their voting stock pursuant to the tender offer.

The closing of the transaction is conditioned on the tender and acceptance of at least a majority of the outstanding voting stock and a majority of the Series C-1 Convertible Preferred Stock as well as other customary conditions. BioTelemetry will acquire any VirtualScopics' shares not purchased in the tender offer in a second-step merger at the same per-share price paid in the tender offer. The closing of the transaction is expected to occur in the second quarter of 2016.

VirtualScopics today reports revenue of $12.7 million for 2015. The Company expects to release its full 2015 financial results in its annual report on Form 10-K later today.

Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, commented: "We are excited to further expand our clinical research offerings with the addition of VirtualScopics' imaging capabilities. This acquisition demonstrates our continued commitment to growing our clinical research business. VirtualScopics possesses an excellent scientific and operational reputation and we look forward to building upon their longstanding relationships with their customers. We would like to welcome VirtualScopics' employees and customers to the BioTelemetry family and we look forward to the successful completion of the merger."

VirtualScopics' Chief Executive Officer, Eric Converse, added: "We believe BioTelemetry is the perfect partner for the future of VirtualScopics. They possess the scale and resources to accelerate our growth plan and lead the company into the future. This is an exciting time for everyone at VirtualScopics and we look forward to joining the BioTelemetry team."

Greenberg Traurig, LLP acted as legal counsel to BioTelemetry. Oppenheimer & Co. acted as exclusive financial advisor and Woods Oviatt Gilman LLP acted as legal counsel to VirtualScopics.

crudeoil24 PremiumMember

03/24/16 9:48 AM

Post #63

Re: #60: @crudeoil24 - VSCP has backlog orders up the yin-yang.

VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that it will report its 2015 fourth quarter and full year financial results before the markets open on Wednesday, March 30, 2016. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. The conference call and webcast information are as follows:

TheInvincibleBull Free

03/01/16 1:03 PM

Post #62

$VSCP watching closely

crudeoil24 PremiumMember

02/29/16 5:40 PM

Post #61

Re: #60: @crudeoil24 - VSCP has backlog orders up the yin-yang.

You want to have shares on March 29 >> > day before year end 10-Q.

crudeoil24 PremiumMember

02/29/16 1:56 PM

Post #60

Re: #59: @ash111 - VSCP another solid move today

VSCP has backlog orders up the yin-yang.

VirtualScopics, Inc. Schedules 2015 Fourth Quarter And Full Year Financial Results Press Release, Conference Call And Webcast
50 minutes ago - DJNF

ROCHESTER, N.Y., Feb. 29, 2016 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced that it will report its 2015 fourth quarter and full year financial results before the markets open on Wednesday, March 30, 2016. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning. The conference call and webcast information are as follows:

Domestic Call Dial In: 877-407-8035

International Call Dial In: 201-689-8035

Conference Call ID: 13631781

ash111

02/02/16 1:39 PM

Post #59

VSCP another solid move today

hweb2

02/01/16 12:37 PM

Post #58

Re: #57: @ash111 - looking great. bought some around 3 last week.

Ha of course you did!

ash111

02/01/16 12:32 PM

Post #57

looking great. bought some around 3 last week.

$Pistol Pete$ Free

01/04/16 2:49 PM

Post #56

Re: #55: @stock1ace1 - **** Around 2.2 Million Float ****

$VSCP 15' Chart

stock1ace1 Free

01/03/16 12:52 AM

Post #55

**** Around 2.2 Million Float ****

stock1ace1 Free

01/03/16 12:48 AM

Post #54

As of November 11, 2015, there were 3,003,231 shares of the registrant’s common stock, $0.001 par value, outstanding.

stock1ace1 Free

12/31/15 2:56 PM

Post #53

Re: #51: @aassnnaapp - I also follow BVXV and EYEG all low

WOW 'QUOTE' "the backlog has grown to $31.9 million and we believe it will continue to grow. Our decision to focus on our core competencies has proven to be the right decision as we continue to strengthen our relationships with large pharma and develop new relationships with biotechs. This year we were chosen to be the sole imaging provider for several of our customers and most recently we were awarded a phase III oncology trial from yet another large pharma company."

stock1ace1 Free

12/31/15 2:41 PM

Post #52

Re: #51: @aassnnaapp - I also follow BVXV and EYEG all low

VSCP ( ( CHART ) )

aassnnaapp Free

11/06/15 8:31 PM

Post #51

Re: #47: @crudeoil24 - Back in @ 3.87 > Trading VSCP each

I also follow BVXV and EYEG all low floaters and VSCP all can be huge winners

feeways

11/06/15 4:38 PM

Post #50

Re: #49: @crudeoil24 - University of Rochester Medical School > 10% share owner.

Well they sold 15% (approx 33,000shs) on the big day last week at approx 6.00 p/sh

They now have about 189,000 so less than 10% now owned

Very good to see that they chose to keep 85%

They have been big sellers over recent years and I believe are cash strapped.

The fact that they sold a small amount for 200,000 USD and then stopped shows they have strong faith for the future.....as indeed do I??

What do you think?

crudeoil24 PremiumMember

11/06/15 1:30 PM

Post #49

University of Rochester Medical School > 10% share owner.

crudeoil24 PremiumMember

11/06/15 1:29 PM

Post #48

Re: #1: @MOMO - VSCP CHART

Thanks for that chart nine years ago...LOL.

crudeoil24 PremiumMember

11/06/15 1:01 PM

Post #47

Re: #46: @aassnnaapp - Missed the pop ! over 30 million backlog

Back in @ 3.87 > Trading VSCP each session. > CEO states: " Backlog at September 30, 2015 was approximately $31.9 million."
Plenty of revenue heading our way. Working with a major pharma on phase III clinicals >>>

2 million float. OS is 3M. > Each session moves on air. Buy the dips.

aassnnaapp Free

11/05/15 9:11 PM

Post #46

Re: #44: @crudeoil24 - " Backlog at September 30, 2015 was approximately

Missed the pop ! over 30 million backlog 2016 sould double revenues easy ! this stock could hit 20 dollars and still be worth only 60 million !

feeways

11/03/15 9:46 AM

Post #45

Re: #43: @magness - Valuation Just look at the technology and marketplace where

Can you explain how this calculation was performed....the converting 100 million market cap to 33usd p/s?

crudeoil24 PremiumMember

11/03/15 8:42 AM

Post #44

Re: #43: @magness - Valuation Just look at the technology and marketplace where

" Backlog at September 30, 2015 was approximately $31.9 million."

magness

11/02/15 1:19 PM

Post #43

Valuation

Just look at the technology and marketplace where it is doing business. Now back to profit with robust growth, huge backlog. VSCP worth at least $100M market cap = $33/sh. IMO

crudeoil24 PremiumMember

11/02/15 10:10 AM

Post #42

Re: #40: @TheFinalCD - VSCP

It appears more investors than traders loading VSCP today. Plenty of upside ahead in upcoming sessions.

stallion

11/02/15 9:11 AM

Post #41

Re: #40: @TheFinalCD - VSCP

Will fly to 8$

TheFinalCD PremiumMember

11/02/15 8:59 AM

Post #40

Re: #38: @crudeoil24 - No dilution. Just 1000's of traders. Many trading

VSCP
ALL OVER THE PLACE BUT ONLY 20K VOL P/M SO FAR

crudeoil24 PremiumMember

10/31/15 2:39 PM

Post #39

Re: #36: @pberger - Advice requested here, please

It is still a low OS equity even with preferred shares converted.
Read yesterday earnings report. That is what drove in the buyers. Absolutely stellar 10-Q. This stock is gradually on its way back to $25. share from a few years ago. You won't be trapped long. This stock is on its way up. Working with a huge pharma now as well. >>GROWING REVENUES.

crudeoil24 PremiumMember

10/31/15 2:31 PM

Post #38

Re: #35: @pberger - Nobody cares to comment about the staggering volume,

No dilution. Just 1000's of traders. Many trading 20,000 share blocks over and over on every few ticks. >>> That's what happens with these low floats. I had several trades myself. I exited position.

stallion

10/31/15 11:05 AM

Post #37

Re: #36: @pberger - Advice requested here, please

Don't wordt u will be able to sell above 6$ on monday...just pick the right time. I am in from 3.90$ still holding for a 100% gain. It will touch 8$ minday imho

pberger

10/31/15 7:14 AM

Post #36

Advice requested here, please

Instead of a marginal profitable scalping in the afternoon, I've been trapped to hold this over the weekend failing to sell when the stock retraced before close. Then I just saw this today

ROCHESTER, N.Y., Sept. 17 /PRNewswire/ -- VirtualScopics, Inc. (Nasdaq:
VSCP) today announced that it has completed a private placement of
$4,350,000 of Series B Convertible Preferred Stock and Warrants with a
group of institutional and other accredited investors. VirtualScopics
currently intends to use the net proceeds from the offering to expand its
sales and marketing efforts, software and technology enhancements and
ongoing operations.
"We are pleased with the closing of this transaction," said Jeff
Markin, president and chief executive officer of VirtualScopics, Inc.
"Completing this offering will strengthen our balance sheet, expand our
shareholder base and enable us to increase our sales and marketing
efforts."
The Series B Preferred Stock is initially convertible into 3,612,057
shares of the Company's common stock at an initial conversion price of
$1.2043 per share, based on the volume weighted average of recent market
prices. The Series B Preferred Stock carries a dividend of 8%, payable
monthly in either cash or in shares of the Company's common stock. The
Company also issued to the investors Warrants to purchase an aggregate of
2,167,234 shares of common stock, half of which have an initial exercise
price at the conversion price per share and half at a 15% premium.
BridgePointe Master Fund Ltd. (managed by Roswell Capital Partners)
acted as the lead investor and BayStar Capital III Investment Fund, L.P.
also participated. The sole placement agent on this transaction was
Canaccord Adams, Inc.
The securities offered in this placement have not been registered under
the Securities Act of 1933, as amended, or state securities laws, and
cannot be offered or sold in the United States absent registration with the
Securities and Exchange Commission or an applicable exemption from the
registration requirements. As part of the transaction, the Company has
agreed to file a registration statement with the SEC covering the resale of
the shares of common stock to be issued in the offering, including the
shares of common stock issuable upon exercise of the warrants. This news
release is neither an offer to sell nor a solicitation of an offer to buy
any of the securities discussed herein and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offer, solicitation
or sale is unlawful. This press release is being issued pursuant to and in
accordance with Rule 135c under the Securities Act.

Given the unfortunate experience I recently had with GBSN about the very toxic potential of some warrants offerings with the stock losing 98% of its value DESPITE POSITIVE NEWS ON PROFITABILITY AND GROWTH POTENTIAL, exactly like VirtualScopics, on view of this offering I'm considering it's now foolish to hold this stock with an entry price of $5.5

GBSN has a size and a business model resembling VSCP

Obvious question is when those warrants will start to be exercised? It looks that they cannot for now(?) even if it amounts of a mind boggling $3.5 profit per share sold (After market price is $4.7)

Of course, it was totally foolish to keep this stock over the weekend, originally I thought VSCP might hold its gains, like e.g. AQXP when it soared a few months ago, but with those warrants I very doubt it now.

What's bugging me is how it is even possible to have 1300x the average volume or 6x the float volume in the same day without anybody commenting about such an extraordinary trading volume?

Your comments and advices are very welcome here.

pberger

10/31/15 5:51 AM

Post #35

Re: #25: @TheFinalCD - FIVE DOLLA HOLLA

Nobody cares to comment about the staggering volume, 1300x the average volume?
The entire float rotated 6x?
How is this even possible? Doesn't that smell untold (and as such criminal) DILUTION?

ClayTrader Free

10/30/15 5:22 PM

Post #34

* * $VSCP Video Chart 10-30-15 * *

Link to Video - click here to watch the technical chart video

pberger

10/30/15 4:09 PM

Post #33

Re: #31: @otcmoneydoubler - $7'S ROUND THE CORNER?

6x the float traded today?
How is that even possible?

crudeoil24 PremiumMember

10/30/15 1:26 PM

Post #32

Re: #31: @otcmoneydoubler - $7'S ROUND THE CORNER?

Traders controlling this 2M float. Up 250% > I'm done for the day. Not holding any over the weekend.

otcmoneydoubler Free

10/30/15 1:21 PM

Post #31

Re: #30: @crudeoil24 - Some brokerages don't have any shares to short.

$7'S ROUND THE CORNER?

crudeoil24 PremiumMember

10/30/15 12:43 PM

Post #30

Re: #29: @otcmoneydoubler - WAS WONDERING HOW LONG B4 NASDAQ JUMPS IN

Some brokerages don't have any shares to short. Trading beast!

otcmoneydoubler Free

10/30/15 11:33 AM

Post #29

Re: #25: @TheFinalCD - FIVE DOLLA HOLLA

WAS WONDERING HOW LONG B4 NASDAQ JUMPS IN TO SAVE SHORTS. THOUGHT THIS MIGHT STOP AT 5.85 BUT ITS TOO POWERFUL.

TheInvincibleBull Free

10/30/15 11:21 AM

Post #28

$6 crushed!!!!!

TheInvincibleBull Free

10/30/15 11:19 AM

Post #27

Come on $6 ;)

TheInvincibleBull Free

10/30/15 11:16 AM

Post #26

$VSCP low floater ;)

TheFinalCD PremiumMember

10/30/15 11:10 AM

Post #25

Re: #24: @crudeoil24 - VSCP > 2M float, finally has great earnings out.

FIVE DOLLA HOLLA

VSCP

crudeoil24 PremiumMember

10/30/15 10:08 AM

Post #24

VSCP > 2M float, finally has great earnings out.

Penny Roger$ Free

02/21/12 6:15 AM

Post #23

~ Monday! $VSCP ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $VSCP ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.

http://stockcharts.com/h-sc/ui?s=VSCP&p=D&b=3&g=0&id=p88783918276&a=237480049

http://stockcharts.com/h-sc/ui?s=VSCP&p=W&b=3&g=0&id=p54550695994

~ Google Finance: http://www.google.com/finance?q=VSCP
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=VSCP#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=VSCP+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=VSCP
Finviz: http://finviz.com/quote.ashx?t=VSCP
~ BusyStock: http://busystock.com/i.php?s=VSCP&v=2

<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=VSCP >>>>>>

http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

WealthyKing Free

03/25/11 9:26 AM

Post #22

ask at 2.39

WealthyKing Free

03/25/11 9:17 AM

Post #21

looks like some interesting movement going on this week

fredfood

01/11/11 12:00 AM

Post #20

Re: #19: @fredfood - VSCP at 2.14 here. Should be turning

Hoping to hit $ 3 as early as tommorow.

fredfood

01/03/11 7:03 AM

Post #19

Re: #18: @kenmoney - It is on Fire. Hopefully, it will catch

VSCP at 2.14 here. Should be turning here for climb to $ 3-4 short term and $ 20 long term.

kenmoney

12/30/10 3:52 PM

Post #18

Re: #17: @fredfood - Hard to believe no one here and this

It is on Fire. Hopefully, it will catch on with a whole lot larger crowd.
Good luck to you and everyone else in here.

Older

VirtualScopics Inc fka VSCP

Followers	8	Posters	30
Posts (Today)	0	Posts (Total)	67
Created	08/06/06	Type	Free
Moderators

Company Website http://www.virtualscopics.com/ Vision: The most precise and reproducible image analysis provider, enabling accelerated clinical trials and improved patient care and safety. VirtualScopics utilizes its patented suite of image analysis algorithms to detect, measure, and analyze specific biological structures from medical image data, such as computed tomography (CT), magnetic resonance imaging (MRI) scans, positron emission tomography (PET), and ultra sound (US). VirtualScopics’ computer-assisted analysis technique provides superior precision and reproducibility, enabling faster and more reliable detection of disease progression or therapeutic benefit, accelerating the clinical trial process, and providing a basis for future diagnostic applications. The company’s proprietary software algorithms can process hundreds of separate medical images taken during an MRI or CT session into a single, anatomically accurate three-dimensional model, providing clinical researchers a previously unobtainable source of reproducible data including the characterization of minute changes over time. This visionary biomedical firm evolved from research initially undertaken at the University of Rochester Medical Center and School of Engineering. VirtualScopics provides unparalleled depth of experience, technological capability, and expertise in imaging for clinical trials. Our services support all aspects of imaging in clinical trials, from design to FDA submission, pre-clinical through Phase IV. Benefits: Fast proof-of-concept studies to determine efficacy Reduction of late-stage attrition via better go/no-go decision making Life-cycle risk reduction via comprehensive quality assurance Regulatory compliant core lab, software, and procedures Comprehensive imaging expertise including protocol design, quality monitoring and radiological consultation Development of novel imaging endpoints Contact: 350 Linden Oaks Rochester, NY 14625 Tel: 585.249.6231 Fax: 585.218.7350 Email: info@virtualscopics.com

Board Info

Posts Today	0
Posts (Total)	67
Posters	30
Moderators

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

VirtualScopics Inc fka VSCP

VirtualScopics Inc fka VSCP

Join the InvestorsHub Community

VirtualScopics Inc fka VSCP

Board Info